Thrombin-Jmi, Thrombocoll Market Report 2026

Thrombin-Jmi, Thrombocoll Market Overview

• The Thrombin-Jmi, Thrombocoll market growth in the historic period has been driven by growth in surgical procedure volumes, wider availability of human thrombin products • Market expansion is supported by increasing demand for efficient intraoperative bleeding management, expansion of trauma and emergency care services • Growth Driver: The Rising Incidence of Bleeding Disorders Drives Growth In The Market • North America was the largest region in 2025.

What Is Covered Under Thrombin-Jmi, Thrombocoll Market?

Thrombin-JMI and Thrombocoll are medical products used to manage bleeding during surgical procedures. Thrombin-Jmi is a human thrombin-based hemostatic agent that controls bleeding during surgery by promoting clot formation. Thrombocoll is a collagen-based hemostatic product that helps stop bleeding by facilitating platelet aggregation and clot formation during surgical procedures. Both products are used in clinical settings to prevent or stop excessive bleeding during surgeries or invasive procedures. The main types of indications in thrombin-jmi, thrombocoll are surgical procedures and trauma management. Surgical procedures are medical operations performed by trained surgeons to treat or manage diseases, injuries, or conditions through the use of instruments, often involving incisions or alterations to the body. These products are available in solution form and powder formulations, catering to various end users such as hospitals, diagnostic centers, and clinics.

What Is The Thrombin-Jmi, Thrombocoll Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for efficient intraoperative bleeding management, expansion of trauma and emergency care services, rising use of biologic hemostats in complex surgeries, ongoing innovation in surgical sealants, growing investments in advanced surgical products. Major trends in the forecast period include increasing use of topical hemostatic agents in surgery, rising demand for rapid bleeding control solutions, expansion of minimally invasive surgical procedures, growing adoption of collagen-based hemostats, enhanced focus on surgical safety and outcomes.

Global Thrombin-Jmi, Thrombocoll Market Segmentation

1) By Indication: Surgical Procedures, Trauma Management 2) By Formulation: Solution Form, Powder Form 3) By End User: Hospitals, Diagnostic Centers And Clinics

What Are The Drivers Of The Thrombin-Jmi, Thrombocoll Market?

The rising incidence of bleeding disorders is expected to propel the growth of the thrombin-jmi, thrombocoll market going forward. Bleeding disorders refer to any abnormal or excessive blood loss, external or internal, due to injury, medical conditions, or clotting disorders. The incidence of bleeding issues is rising due to an aging population and the increased use of anticoagulants, both of which contribute to higher risks of bleeding complications. Thrombin-JMI and Thrombocoll help manage bleeding issues by promoting clot formation, with Thrombin-JMI activating the clotting cascade and Thrombocoll enhancing platelet aggregation and fibrin formation at the wound site. For instance, in Aoril 2025, according to Pfizez Inc a US-based pharmaceutical and biotechnology corporation, an Australia-based non-profit organization, in the 2023/24 period, the UK haemophilia A and B patient population exceeded 11,800 individuals, underscoring a sizable and clinically significant treated population. Therefore, the rising incidence of bleeding issues cases drives growth of the thrombin-jmi, thrombocoll industry. The increasing number of surgical procedures is expected to propel the growth of the thrombin-JMI, thrombocoll market going forward. Surgical procedures are medical operations performed to treat diseases, injuries, or conditions by manually altering or removing body tissues, often involving incisions or other invasive techniques. The number of surgical procedures is increasing due to an aging population that requires more medical interventions and advancements in minimally invasive techniques that improve safety and recovery times. Thrombin-JMI and Thrombocoll are hemostatic agents used in surgeries to control bleeding, with Thrombin-JMI activating fibrinogen for clot formation and Thrombocoll providing a collagen scaffold to stimulate platelet aggregation. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing number of surgical procedure cases drives growth in the thrombin-jmi, thrombocoll industry. The increasing aging population is expected to propel the growth of the Thrombin-JMI, Thrombocoll market going forward. An aging population refers to a demographic shift where the proportion of elderly individuals in society grows due to longer life expectancy and lower birth rates. The aging population is increasing due to advancements in healthcare that have extended life expectancy and declining birth rates in many countries, leading to a higher proportion of elderly individuals. Thrombin-JMI and Thrombocoll help the aging population by promoting blood clotting and controlling bleeding, which is crucial for older adults who may face slower wound healing and increased bleeding risks due to age-related conditions. For instance, in January 2024, according to the U.S. Census Bureau, a US-based government agency, the U.S. population aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. Consequently, the proportion of this age group within the total population is projected to rise from 17% to 23% during the same period. Therefore, the increasing aging population cases drive growth in the thrombin-jmi, thrombocoll industry.

Key Players In The Global Thrombin-Jmi, Thrombocoll Market

Major companies operating in the thrombin-jmi, thrombocoll market are Pfizer Inc

Regional Insights

North America was the largest region in the thrombin-jmi, thrombocoll market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Thrombin-Jmi, Thrombocoll Market?

The thrombin-jmi, thrombocoll market consists of sales of hemostatic kits, reconstitution kits, coseal, floseal hemostatic matrix, and tachoSil. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thrombin-Jmi, Thrombocoll Market Report 2026?

The thrombin-jmi, thrombocoll market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thrombin-jmi, thrombocoll industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.